Get Instant Summarized Text (Gist) The FDA has approved Onapgo, a wearable subcutaneous apomorphine infusion device, for treating motor fluctuations in advanced Parkinson's disease. It offers ...

The wearable pump is designed to provide a continuous subcutaneous infusion of Supernus’ apomorphine (Apokyn). The drug is intended for patients experiencing “off” periods, where medication ...

THURSDAY, Feb. 6, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion ...

He invented the first wearable infusion pump and founded his first medical device company, AutoSyringe, Inc., soon thereafter, where he pioneered the design and adoption of the first portable ...

The wearable device is the first subcutaneous apomorphine infusion device for Parkinson's and provides continuous treatment during the day, Supernus noted. "As Parkinson's disease progresses ...